UMMS Affiliation

Department of Microbiology and Physiological Systems

Publication Date

4-1-2017

Document Type

Article

Disciplines

Cancer Biology | Nanomedicine | Neoplasms | Oncology

Abstract

Engineering of this semisynthetic Salmonella nanoparticle mimic introduces a new platform technology that has the capacity to be applied to various chemotherapeutic drugs to overcome multi-drug resistance in tumors.

Rights and Permissions

© Beth A McCormick

DOI of Published Version

10.2217/nnm-2017-0005

Source

Nanomedicine (Lond). 2017 Apr;12(7):705-710. doi: 10.2217/nnm-2017-0005. Epub 2017 Mar 21. Link to article on publisher's site

Related Resources

Link to Article in PubMed

Keywords

Salmonella, cancer, drug delivery, effector proteins, multidrug resistance, nanoparticles, therapeutic adjuvant

Journal/Book/Conference Title

Nanomedicine (London, England)

PubMed ID

28322607

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.